193 related articles for article (PubMed ID: 2981106)
21. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
[TBL] [Abstract][Full Text] [Related]
22. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
[TBL] [Abstract][Full Text] [Related]
23. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
[TBL] [Abstract][Full Text] [Related]
24. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
[TBL] [Abstract][Full Text] [Related]
27. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
28. [The HTL IV virus: a new human retrovirus without pathogen protection against the HTLV III/LAV virus?].
Mboup S; Essex M; Kank P; Ndoye I; Barin F; Samba ; Boye CS; Ricard D; Denis F; Romet JL
Afr J Sex Transmi Dis; 1986 Oct; 2(2):81-4. PubMed ID: 12281131
[TBL] [Abstract][Full Text] [Related]
29. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.
Murphey-Corb M; Martin LN; Rangan SR; Baskin GB; Gormus BJ; Wolf RH; Andes WA; West M; Montelaro RC
Nature; 1986 May 22-28; 321(6068):435-7. PubMed ID: 3012358
[TBL] [Abstract][Full Text] [Related]
30. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
31. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
[TBL] [Abstract][Full Text] [Related]
32. The AIDS epidemic.
Landesman SH; Ginzburg HM; Weiss SH
N Engl J Med; 1985 Feb; 312(8):521-5. PubMed ID: 2982097
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk of transmission of HTLV III infections to staff at a London hospital, 1982-85.
Shanson DC; Evans R; Lai L
J Hosp Infect; 1985 Dec; 6 Suppl C():15-22. PubMed ID: 2868048
[TBL] [Abstract][Full Text] [Related]
34. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.
Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G
Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173
[TBL] [Abstract][Full Text] [Related]
35. Needlestick transmission of HTLV-III from a patient infected in Africa.
Lancet; 1984 Dec; 2(8416):1376-7. PubMed ID: 6150372
[TBL] [Abstract][Full Text] [Related]
36. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
37. Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire.
Biggar RJ; Melbye M; Kestens L; de Feyter M; Saxinger C; Bodner AJ; Paluko L; Blattner WA; Gigase PL
Br Med J (Clin Res Ed); 1985 Mar; 290(6471):808-10. PubMed ID: 2983820
[TBL] [Abstract][Full Text] [Related]
38. AIDS guidelines.
Berger R
Sun; 1986 Apr; ():15A. PubMed ID: 12314207
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome.
Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ
Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397
[TBL] [Abstract][Full Text] [Related]
40. Risk of transmission of HTLV-III by needle stick.
DuBeau CE
N Engl J Med; 1985 Apr; 312(17):1128-9. PubMed ID: 2984566
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
